These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2143868)
1. Establishment of a human T-cell hybridoma producing an MLR suppressing factor: relationship to the mechanism of action of donor-specific transfusion. Haisa M; Sakagami K; Orita K Transplant Proc; 1990 Aug; 22(4):1977-80. PubMed ID: 2143868 [No Abstract] [Full Text] [Related]
2. Induction of suppressor T cells by donor-specific blood transfusions: establishment of a human T-cell hybridoma producing an MLR suppressant factor. Haisa M; Sakagami K; Kawamura T; Niguma T; Fujiwara T; Kusaka S; Matsuoka J; Shiozaki S; Fujiwara T; Onoda T Transplant Proc; 1991 Feb; 23(1 Pt 1):196-9. PubMed ID: 1824973 [No Abstract] [Full Text] [Related]
3. [Induction of suppressor T cells by donor-specific blood transfusion (DST): establishment of a human T cell hybridoma producing an MLR suppressing factor]. Haisa M Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):367-73. PubMed ID: 1831242 [TBL] [Abstract][Full Text] [Related]
4. Analysis of immunomodulation induced by donor-specific blood transfusion (DST): establishment of a human-mouse hybridoma secreting the MLR inhibiting factor. Kawamura T; Sakagami K; Orita K Transplant Proc; 1989 Feb; 21(1 Pt 2):1802-5. PubMed ID: 2523592 [No Abstract] [Full Text] [Related]
6. Induction of suppressor T cells in vitro by an autologous alloreactive T cell line propagated from a DSBT-enhanced rat renal allograft. Ruiz P; Baldwin WM; Sanfilippo F Transplant Proc; 1989 Apr; 21(2):3289-91. PubMed ID: 2565616 [No Abstract] [Full Text] [Related]
7. RATG treatment induces suppressor cells in primates. Emara M; Carver FM; Thomas JM Transplant Proc; 1991 Feb; 23(1 Pt 1):302-4. PubMed ID: 1824984 [No Abstract] [Full Text] [Related]
8. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization. Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594 [No Abstract] [Full Text] [Related]
9. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation. Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929 [No Abstract] [Full Text] [Related]
10. Analysis of suppressor T cells induced by donor-specific transfusion (DST): establishment of a human T cell hybridoma producing an antigen-nonspecific suppressor factor. Fujiwara T; Sakagami K; Kusaka S; Uda M; Orita K Transpl Int; 1992; 5 Suppl 1():S653-8. PubMed ID: 14621901 [TBL] [Abstract][Full Text] [Related]
11. Spleen mixed leukocyte chimerism and induction of tolerance in rat renal allograft recipients conditioned with donor-specific blood transfusions and cyclosporine. Llull R; Mañez R; Domenech N; Starzl TE; Black KS; Hewitt CW Transplant Proc; 1995 Aug; 27(4):2374-6. PubMed ID: 7652844 [No Abstract] [Full Text] [Related]
12. Effect of DST combined with cyclosporine on lymphocyte subsets of potential recipients for living-related donor renal allograft. Murai M; Nakamura H; Sekiguchi S; Shimizu S; Nakajima F Transplant Proc; 1994 Aug; 26(4):1950-1. PubMed ID: 8066631 [No Abstract] [Full Text] [Related]
13. A human-mouse T-cell hybridoma-derived lymphokine inhibits thymidine uptake of T-lymphocytes. Laus R; Müller-Ruchholtz W Transplant Proc; 1989 Feb; 21(1 Pt 1):96-7. PubMed ID: 2784914 [No Abstract] [Full Text] [Related]
14. The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies. Duffy B; Tyler J; Anderson C; Hanto D; Flye W; Rodey G Transplant Proc; 1987 Feb; 19(1 Pt 1):753-4. PubMed ID: 2978930 [No Abstract] [Full Text] [Related]
15. MLR suppression and MLR-suppressor activity induced by thoracic duct drainage prior to transplantation. Ono Y; Ohshima S; Kinukawa T; Matsuura O; Hirabayashi S Transplant Proc; 1987 Feb; 19(1 Pt 3):1985-7. PubMed ID: 2978887 [No Abstract] [Full Text] [Related]
16. Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation. Bean MA; Mickelson E; Yanagida J; Ishioka S; Hansen JA Transplant Proc; 1988 Dec; 20(6):1084-6. PubMed ID: 2974196 [No Abstract] [Full Text] [Related]
17. Role of donor specific blood transfusions in prolongation of kidney graft survival. Matsumoto T; Sakagami K; Orita K Transplant Proc; 1987 Feb; 19(1 Pt 3):2264-7. PubMed ID: 2950636 [No Abstract] [Full Text] [Related]
18. Induction of antiidiotypic antibodies by donor-specific blood transfusions. Establishment of a human-mouse hybridoma secreting the MLR-inhibiting factor. Kawamura T; Sakagami K; Haisa M; Morisaki F; Takasu S; Inagaki M; Oiwa T; Orita K Transplantation; 1989 Sep; 48(3):459-63. PubMed ID: 2528850 [TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanism of peripheral tolerance: in vitro evidence for dominant suppression of host responses during the maintenance phase of tolerance to renal allografts in miniature swine. Wu A; Yamada K; Ierino FL; Vagefi PA; Sachs DH Transpl Immunol; 2003; 11(3-4):367-74. PubMed ID: 12967789 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive factors in patients after donor-specific transfusion with administration of cyclosporine. Yuzawa K; Otsuka M; Yu Y; Sharma N; Iwasaki H; Fukao K; Iwasaki Y Transplant Proc; 1991 Feb; 23(1 Pt 2):1036-8. PubMed ID: 1824884 [No Abstract] [Full Text] [Related] [Next] [New Search]